RNU7-62P

Across TCGA pan-cancer cohorts, RNU7-62P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU7-62P data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher RNU7-62P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-62P expression acts as an unfavorable survival marker.

TGCT, BLCA, and HNSC are the cancer types where RNU7-62P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	OS	Tertile	All	0.672	0.991	<.001	102	view →
BLCA	DFS	Tertile	All	0.194	0.627	.007	54	view →
HNSC	DFS	Tertile	II,III,IV	0.149	0.594	.016	54	view →
LIHC	DFS	Tertile	All	0.067	0.544	<.001	54	view →
STAD	OS	Tertile	III,IV	0.163	0.517	.007	45	view →
KIRC	OS	Tertile	All	0.488	0.808	.005	33	view →
LGG	DFS	Tertile	All	0.185	0.832	<.001	18	view →
LUAD	OS	Tertile	All	0.016	0.835	<.001	18	view →
COAD	OS	Tertile	All	0.373	0.809	.041	12	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU7-62P–TGCT (OS)

Open the TGCT breakdown →